Literature DB >> 12352001

Acute immunoinflammatory neuropathy: update on Guillain-Barré syndrome.

Hans-Peter Hartung, Hugh J Willison, Bernd C Kieseier.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12352001     DOI： 10.1097/00019052-200210000-00008

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN： 1350-7540            Impact factor:   5.710


× No keyword cloud information.
  14 in total

Review 1.  [Plasma exchange as a therapeutic option in neurological disorders].

Authors:  H C Lehmann; H P Hartung; G R Hetzel; B C Kieseier
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

2.  [Guillain-Barre syndrome complicated on post-operation with renal carcinoma and meningioma: a case report].

Authors:  S Xu; Y S Wang; S Li; H Y Liu
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2019-08-18

3.  α(M)β(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barré syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitro.

Authors:  Nejla Yosef; Eroboghene E Ubogu
Journal:  J Cell Physiol       Date:  2012-12       Impact factor: 6.384

Review 4.  The role of chemokines in Guillain-Barré syndrome.

Authors:  Sharon Chiang; Eroboghene E Ubogu
Journal:  Muscle Nerve       Date:  2013-07-27       Impact factor: 3.217

Review 5.  [The significance of intravenous immunoglobulin in treatment of immune-mediated polyneuropathies].

Authors:  M Stangel; H-P Hartung; R Gold; B C Kieseier
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

Review 6.  The usefulness of immunotherapy in pediatric neurodegenerative disorders: A systematic review of literature data.

Authors:  Giovanna Vitaliti; Omidreza Tabatabaie; Nassim Matin; Caterina Ledda; Piero Pavone; Riccardo Lubrano; Agostino Serra; Paola Di Mauro; Salvatore Cocuzza; Raffaele Falsaperla
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

7.  Translational strategies in peripheral neuroinflammation and neurovascular repair.

Authors:  Eroboghene E Ubogu
Journal:  Transl Neurosci       Date:  2012-12-01       Impact factor: 1.757

8.  Extracting postmarketing adverse events from safety reports in the vaccine adverse event reporting system (VAERS) using deep learning.

Authors:  Jingcheng Du; Yang Xiang; Madhuri Sankaranarayanapillai; Meng Zhang; Jingqi Wang; Yuqi Si; Huy Anh Pham; Hua Xu; Yong Chen; Cui Tao
Journal:  J Am Med Inform Assoc       Date:  2021-07-14       Impact factor: 4.497

9.  Flaccid paralysis following subarachnoid block: A diagnostic dilemma.

Authors:  Tanvir Samra; Vikas Saini; Tenzin Kyizom
Journal:  Indian J Anaesth       Date:  2015-08

10.  CCR2 gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain-Barré syndrome.

Authors:  Furong Yuan; Nejla Yosef; Chetan Lakshmana Reddy; Ailing Huang; Sharon C Chiang; Hafiza Rahman Tithi; Eroboghene E Ubogu
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.